Paper36958586
Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapies.
Asif K and 7 others. J Adv Res, 2024. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapies. Papers, record 36958586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958586
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapies.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Silver | Major topic |
| Neoplasms | Major topic |
| Mice | |
| Animals | |
| Humans | |
| Reactive Oxygen Species | |
| Nitroprusside | |
| Peroxynitrous Acid | |
| Hydrogen Peroxide |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11701324 | Ten years of protein kinase B signalling: a hard Akt to follow. | Trends Biochem Sci | 2001 | https://conductscience.org/library/papers/11701324 | PubMed |
| 2 | 35211255 | Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry. | Chem Sci | 2022 | https://conductscience.org/library/papers/35211255 | PubMed |
| 3 | 22809647 | Mechanisms of the pH dependent generation of hydroxyl radicals and oxygen induced by Ag nanoparticles. | Biomaterials | 2012 | https://conductscience.org/library/papers/22809647 | PubMed |
| 4 | 20175529 | Ion release kinetics and particle persistence in aqueous nano-silver colloids. | Environ Sci Technol | 2010 | https://conductscience.org/library/papers/20175529 | PubMed |
| 5 | 33036656 | High-throughput approaches for precision medicine in high-grade serous ovarian cancer. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/33036656 | PubMed |
| 6 | 19698986 | Antiangiogenic properties of silver nanoparticles. | Biomaterials | 2009 | https://conductscience.org/library/papers/19698986 | PubMed |
| 7 | 25569205 | N-Pyridineium-2-yl Darrow Red analogue: unique near-infrared lysosome-biomarker for the detection of cancer cells. | Anal Chem | 2015 | https://conductscience.org/library/papers/25569205 | PubMed |
| 8 | 27960409 | An Intelligent and Tumor-Responsive Fe2+ Donor and Fe2+-Dependent Drugs Cotransport System. | ACS Appl Mater Interfaces | 2016 | https://conductscience.org/library/papers/27960409 | PubMed |
| 9 | 21468968 | Annexin V/7-AAD staining in keratinocytes. | Methods Mol Biol | 2011 | https://conductscience.org/library/papers/21468968 | PubMed |
| 10 | 9403032 | Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. | Mutat Res | 1997 | https://conductscience.org/library/papers/9403032 | PubMed |
| 11 | 18359055 | The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. | Water Res | 2008 | https://conductscience.org/library/papers/18359055 | PubMed |
| 12 | 28109747 | Silver nanoparticles induce hormesis in A549 human epithelial cells. | Toxicol In Vitro | 2017 | https://conductscience.org/library/papers/28109747 | PubMed |
| 13 | 20380484 | Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity. | Expert Opin Drug Metab Toxicol | 2010 | https://conductscience.org/library/papers/20380484 | PubMed |
| 14 | 30048028 | Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/30048028 | PubMed |
| 15 | 27180073 | Differential genotoxicity mechanisms of silver nanoparticles and silver ions. | Arch Toxicol | 2017 | https://conductscience.org/library/papers/27180073 | PubMed |
| 16 | 16968214 | Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. | Annu Rev Pharmacol Toxicol | 2007 | https://conductscience.org/library/papers/16968214 | PubMed |
| 17 | 23876760 | Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. | Biomaterials | 2013 | https://conductscience.org/library/papers/23876760 | PubMed |
| 18 | 28063851 | Fluorescent real-time quantitative measurements of intracellular peroxynitrite generation and inhibition. | Anal Biochem | 2017 | https://conductscience.org/library/papers/28063851 | PubMed |
| 19 | 33168016 | Elucidating the cellular response of silver nanoparticles as a potential combinatorial agent for cisplatin chemotherapy. | J Nanobiotechnology | 2020 | https://conductscience.org/library/papers/33168016 | PubMed |
| 20 | 35582641 | Fenton metal nanomedicines for imaging-guided combinatorial chemodynamic therapy against cancer. | Asian J Pharm Sci | 2022 | https://conductscience.org/library/papers/35582641 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41754782 | Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754782 | PubMed |
| 41149286 | Characterization of M11-like and OC125-like Monoclonal Antibody Binding to CA125 Tandem Repeats. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/41149286 | PubMed |
| 40611788 | Multi-Functional Polydopamine-Mucin Hollow Particles Provide Tunable Shell Permeability, ROS Scavenging, Tissue Adhesion, and Lubricity for Biomedical Applications. | Small | 2025 | https://conductscience.org/library/papers/40611788 | PubMed |
| 39303357 | Exploration of organoids in ovarian cancer: From basic research to clinical translation. | Transl Oncol | 2024 | https://conductscience.org/library/papers/39303357 | PubMed |
| 39175687 | Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery application. | RSC Adv | 2024 | https://conductscience.org/library/papers/39175687 | PubMed |
| 39092168 | Targeted therapy in high grade serous ovarian Cancer: A literature review. | Gynecol Oncol Rep | 2024 | https://conductscience.org/library/papers/39092168 | PubMed |
| 38063781 | Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38063781 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36958586
GET https://conductscience.org/api/papers/v1/36958586/references?page=2